Adverse effects of corticosteroids on the cardiovascular system

Canadian Journal of Cardiology

Volumn 16, Issue 4, 2000, Pages 505-511

  Sholter, Dalton E ^a   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Atherosclerosis; Hypertension; Lipids; Morbidity

Indexed keywords

CHOLESTEROL; CORTICOSTEROID; DEOXYCORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID ANTAGONIST; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; NORADRENALIN; PREDNISOLONE; PREDNISONE; TRIACYLGLYCEROL; TRIAMCINOLONE;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CHOLESTEROL BLOOD LEVEL; CORTICOSTEROID THERAPY; DYSLIPIDEMIA; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART VENTRICLE SEPTUM RUPTURE; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INFLAMMATORY DISEASE; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; NONHUMAN; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ARRHYTHMIA; GLUCOCORTICOIDS; HEART; HEART RUPTURE, POST-INFARCTION; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; THROMBOPHILIA;

EID: 0034095183     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Bagdade JD, Porte D Jr, Bierman EL. Steroid-induced lipemia. A complication of high-dosage corticosteroid therapy. Arch Intern Med 1970;125:129-34.
2. el-Shaboury AH, Hayes TM. Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy. BMJ 1973;ii:85-6.
3. Jefferys DB, Lessof MH, Mattock MB. Corticosteroid treatment, serum lipids and coronary artery disease. Postgrad Med J 1980;56:491-3.
4. Curtis JJ, Galla JH, Woodford SY, Lucas BA, Luke RG. Effect of alternate-day prednisone on plasma lipids in renal transplant recipients. Kidney Int 1982;22:42-7.
5. Becker DM, Markakis M, Sension M, et al. Prevalence of hyperlipidemia in heart transplant recipients. Transplantation 1987;44:323-5.
6. Becker DM, Chamberlain B, Swank R, et al. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Med 1988;85:632-8.
7. Cattran DC, Steiner G, Wilson DR, Fenton SA. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Intern Med 1979;91:554-9.
8. Ettinger WH, Goldberg AP, Applebaum-Bowden D, Hazzard WR. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am J Med 1987;83:503-8.
9. Ettinger WH, Klinefelter HF, Kwiterovitch PO. Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis 1987;63:167-72.
10. Ettinger WH Jr, Hazzard WR. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 1988;37:1055-8.
11. Zimmerman J, Fainaru M, Eisenberg S. The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. Metabolism 1984;33:521-6.
12. Henze K, Chait A, Albers JJ, Bierman EL. Hydrocortisone decreases the internalization of low density lipoprotein in cultured human fibroblasts and arterial smooth muscle cells. Eur J Clin Invest 1983;13:171-7.
13. Hirsch LJ, Mazzone T. Dexamethasone modulates lipoprotein metabolism in cultured human monocyte-derived macrophages. Stimulation of scavenger receptor activity. J Clin Invest 1986;77:485-90.
14. Plotz CM, Knowlton AI, Ragan C. The natural history of Cushing's syndrome. Am J Med 1952;13:597-611.
15. Taskinen M, Nikkila EA, Pelkonen R, Sane T. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 1982;57:619-26.
16. Yanovski JA, Cutler Jr GM. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 1994;23:487-509.
17. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
18. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975;58:243-64.
19. Cosgriff SW, Diefenbach AF, Vogt Jr W. Hypercoagulability of the blood associated with ACTH and cortisone therapy. Am J Med 1950;9:752-6.
20. Chaudhuri MD, Bhan GL. Deep vein thrombosis: a side effect of steroid therapy. Br J Clin Pract 1984;33:118-9.
21. Lown B, Arons WL, Ganong WF, Vazifdar JP, Levine SA. Adrenal steroids and auriculoventricular conduction. Am Heart J 1955;50:760-9.
22. Sjoberg HE, Blomback M, Granberg PO. Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing's syndrome. Acta Med Scand 1976;199:95-8.
23. Small M, Lowe GDO, Forbes CD, Thomson JA. Thromboembolic complications in Cushing's syndrome. Clin Endocrinol 1983;19:503-11.
24. Vassalli J, Hamilton J, Reich E. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell 1976;8:271-81.
25. Prydz H, Lyberg T. Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro. Biochem Pharmacol 1980;29:9-14.
26. Samsioe G. Coagulation and anticoagulation effects of contraceptive steroids. Am J Obstet Gynecol 1994;170:1523-7.
27. Ansell JE, Tiarks C, Fairchild VK. Coagulation abnormalities associated with the use of anabolic steroids. Am Heart J 1993;125:367-71.
28. Ferenchick GS. Are androgenic steroids thrombogenic? N Engl J Med 1990;322:476.
29. Whitworth JA. Mechanisms of glucocorticoid-induced hypertension. Kidney Int 1987;31:1213-24.
30. Krakoff LR, Selvadurai R, Sutter E. Effect of methylprednisolone upon arterial pressure and the renin angiotensin system in the rat. Am J Physiol 1975;228:613-7.
31. Haak D, Mohring J, Mohring B, Petri M, Hackenthal E. Comparative study on development of corticosterone and DOCA hypertension in rats. Am J Physiol 1977;233:F403-11.
32. Hall JE, Morse CL, Smith MJ, Young DB, Guyton AC. Control of arterial pressure and renal function during glucocorticoid excess in dogs. Hypertension 1980;2:139-48.
33. Nakamoto H, Suzuki H, Kageyama Y, et al. Characterization of alterations of hemodynamics and neuroendocrine hormones in dexamethasone-induced hypertension in dogs. Clin Exp Hypertens 1991;A13:587-606.
34. Sudhir K, Jennings GL, Esler MD, et al. Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension 1989;13:416-21.
35. Pirpiris M, Yeung S, Dewar E, Jennings GL, Whitworth JA. Hydrocortisone-induced hypertension in men. The role of cardiac output. Am J Hypertens 1993;6:287-94.
36. Connell JMC, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertension 1987;5:425-33.
37. Whitworth JA, Gordon D, Andrews J, Scoggins BA. The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens 1989;7:537-49.
38. Jackson SHD, Beevers DG, Myers K. Does long-term low-dose corticosteroid therapy cause hypertension? Clin Sci (Colch) 1981;61(SuPPl 7):381s-3s.
39. Walker BR, Edwards CR. New mechanisms for corticosteroid-induced hypertension. Br Med Bull 1994;50:342-55.
40. Walker BR, Yau JL, Brett LP, et al. 11 Beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology 1991;129:3305-12.
41. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of trie α1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 1991;88:385-9.
42. Kennedy B, Ziegler MG. Cardiac epinephrine synthesis. Regulation by a glucocorticoid. Circulation 1991;84:891-5.
43. 2+ uptake and [3H] dihydropyridine binding in A7r5 vascular smooth muscle cells. Am J Physiol 1991;261:C106-14.
44. + transport in vascular smooth muscle through the glucocorticoid receptor-mediated mechanism. Am J Hypertens 1993;6:736-44.
45. Grunfeld JP. Glucocorticoids in blood pressure regulation. Horm Res 1990;34:111-3.
46. Kanse SM, Takahashi K, Warren JB, Ghatei M, Bloom SR. Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. Eur J Pharmacol 1991;199:99-101.
47. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-7.
48. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Takeda T. Glucocorticoids and atrial naturiuretic factor receptors on vascular smooth muscle. Hypertension 1990;16:581-6.
49. Rascher W, Dietz R, Schomig A, et al. Modulation of sympathetic vascular tone by prostaglandins in corticosterone-induced hypertension in rats. Clin Sci (Colch) 1979;57(Suppl 5):235s-7s.
50. Whitworth JA. Studies on the mechanisms of glucocorticoid hypertension in humans. Blood Press 1994;3:24-32.
51. Klett C, Hellmann W, Hackenthal E, Ganten D. Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats. Clin Exp Hypertens 1993;15:683-708.
52. Greene MA, Gordon A, Boltax AJ. Clinical and cardiodynamic effects of adrenocortical steroids in congestive heart failure. Circulation 1960;21:661-71.
53. Ito T, Murata M, Kamiyama A. Experimental study of cardiomyopathy induced by glucocorticoids. Jpn Circ J 1979;43:1043-7.
54. Czerwinski SM, Kurowski TT, McKee EE, Zak R, Hickson RC. Myosin heavy chain turnover during cardiac mass changes by glucocorticoids. J Appl Physiol 1991;70:300-5.
55. t - methylhistidine. Biochem J 1979;178:139-46.
56. Rannels SR, Jefferson LS. Effects of glucocorticoids on muscle protein turnover in perfused rat hemicorpus. Am J Physiol 1980;238:E564-72.
57. Kurowski TT, Chatterton RT Jr, Hickson RC. Glucocorticoid-induced cardiac hypertrophy: additive effects of exercise. J Appl Physiol 1984;57:514-9.
58. Akatsuka N, Yamaguchi T, Matsuda M. Long-term effect of corticosteroids on cardiac function. Jpn Heart J 1974;15:443-54.
59. Somerville W, Levine HD, Thorn GW. The electrocardiogram in Addison's disease. Medicine 1951;30:43-79.
60. Singh RG, Kassir M, Roistacher N, Lerman BB, Kligfield P. Acceleration of atrioventricular conduction during corticosteroid therapy. Am Heart J 1993;125:1432-4.
61. Thompson JF, Chalmers DHK, Wood RFM, Kirkham SR, Morris PJ. Sudden death following high dose intravenous methylprednisolone. Transplantation 1983;36:594-6.
62. Smith RS, Warren DJ. Effects of high-dose intravenous methylprednisolone on circulation in humans. Transplantation 1983;35:349-51.
63. Nasswetter O, Pineiro DJ, Garcia Morteo OM, et al. Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy. Clin Rheum 1984;3:29-31.
64. Fujimoto S, Kondoh H, Yamamoto Y, Hisanaga S, Tanaka K. Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy. Am J Nephrol 1990;10:231-6.
65. Novak E, Stubbs SS, Seckman CE, Hearron MS. Effects of a single large intravenous dose of methylprednisolone sodium succinate. Clin Pharmacol Ther 1970;11:711-7.
66. White KP, Driscoll MS, Rothe MJ, Grant-Kels JM. Severe adverse cardiovascular effects of pulse steroid therapy: is continuous cardiac monitoring necessary? J Am Acad Dermatol 1994;30:768-73.
67. Edwards LC, Dunphy JE. Wound healing. II. Injury and abnormal repair. N Engl J Med 1958;259:275-85.
68. Hepper NG, Pruitt RD, Donald DE, et al. The effect of cortisone on experimentally produced myocardial infarcts. Circulation 1955;11:742-8.
69. Bulkley BH, Roberts WC. Steroid therapy during myocardial infarction. A cause of delayed healing and of ventricular aneurysm. Am J Med 1974;56:244-50.
70. Roberts R, DeMello V, Sobel BE. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 1976;53:1204-6.
71. Silverman HS, Pfeifer MP. Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction. Am J Cardiol 1987;59:363-4.
72. Shizukuda Y, Miura T, Ishimoto R, Itoya M, Iimura O. Effect of prednisolone on myocardial infarct healing: characteristics and comparison with indomethacin. Can J Cardiol 1991;7:447-54.
73. Sakai K, Hosoda S, Shimamoto K. Late rupture of left ventricular true aneurysm after acute myocardial infarction. Clin Cardiol 1993;16:573-5.